Lifesaving flu vaccines at heart of £160 million boost for life sciences

first_imgI want patients to continue to be at the front of the queue for the best treatments availableJeremy Hunt, Health Secretary Professor Sir John Bell, the Regius Professor of Medicine at Oxford University, will use a speech at the University of Birmingham today to set out how the country can build British life science into a “globally unique industry” while improving outcomes for patients.”We have created a strategy which capitalises on our strong science base to further build the industry into a globally-unique and internationally competitive life sciences eco-system, supported by collaboration across industry, Government, the NHS, academia, and research funders to deliver health and wealth,” he will say.Each year thousands of lives depend on health officials accurately predicting which strains of influenza will strike the UK and preparing the right vaccines to thwart them.In winter 2014-15, there were an estimated 44,000 excess deaths partly attributed to ineffective vaccines.Health Secretary Jeremy Hunt will today announce £14 million of funding support for 11 medical technology research centres to bring new technologies to patients by encouraging collaboration between industry and the NHS.”I want patients to continue to be at the front of the queue for the best treatments available, whether that means early access to trials, giving staff brand new innovations and technology to work with, or being at the heart of research to share best practice quickly across the health and social care system,” he will say.”A strong and growing life sciences sector ensures this, particularly as we negotiate our exit from the EU.” Want the best of The Telegraph direct to your email and WhatsApp? Sign up to our free twice-daily  Front Page newsletter and new  audio briefings.center_img A new national centre to investigate cures for influenza will be at the heart of a £160 million Government boost for the UK’s research sector, ministers will announced.The facility is also expected to manufacture large-scale vaccines to tackle polio and a host of other illnesses.The announcement coincides with the publication of a review recommending the future strategy for Britain’s £64 billion life sciences industry as the UK prepares to leave the EU.last_img

Leave a Reply

Your email address will not be published. Required fields are marked *